Hypertension control after intracerebral hemorrhage among varying small vessel disease etiologies

Alvin S Das1,2, Akashleena Mallick3,4, Samantha A Mora3,4

  • 1Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA. adas4@bidmc.harvard.edu.

Insights

Cerebral small vessel disease (cSVD) severity and subtype predict long-term hypertension control in patients after intracerebral hemorrhage (ICH). More severe forms of hypertensive-cSVD (HTN-cSVD) are linked to worse blood pressure control post-ICH.

Area of Science:

  • Neurology
  • Cardiovascular Science
  • Radiology

Background:

  • Intracerebral hemorrhage (ICH) is linked to cerebral small vessel disease (cSVD), encompassing cerebral amyloid angiopathy (CAA) and hypertensive-cSVD (HTN-cSVD).
  • Hypertensive-cSVD presents as strictly deep or mixed-location ICH/microbleeds, with mixed-location indicating a more severe form.
  • This study investigates the relationship between HTN-cSVD severity and long-term hypertension control after ICH.

Purpose of the Study:

  • To test the hypothesis that more severe forms of HTN-cSVD are associated with poorer hypertension control during long-term follow-up.
  • To explore the association between cSVD etiology/severity and systolic blood pressure (SBP) in ICH survivors.

Main Methods:

  • Classified 796 non-traumatic ICH survivors into CAA, strictly deep ICH/microbleeds, and mixed-location ICH/microbleeds groups.
  • Quantified cSVD burden using a validated MRI-based score (0-6 points).
  • Employed a multivariable linear mixed-effects model to assess the association of average follow-up SBP with cSVD characteristics, adjusting for covariates.

Main Results:

  • Survivors with CAA-related ICH had lower median SBP (138 mmHg) compared to strictly deep ICH (141 mmHg) and mixed-location ICH/microbleeds (142 mmHg).
  • Mixed-location ICH/microbleeds (effect: +3.8 mmHg, p=0.01) and increasing cSVD severity (effect: +1.8 mmHg per score point, p=0.03) were significantly associated with higher follow-up SBP.
  • Follow-up duration was a median of 48.8 months.

Conclusions:

  • cSVD severity and subtype are significant predictors of long-term hypertension control in ICH patients.
  • Patients with more severe cSVD, particularly mixed-location ICH/microbleeds, exhibit poorer hypertension management post-ICH.
  • These findings highlight the importance of considering cSVD characteristics for tailored hypertension management strategies in ICH survivors.
Abstract